Prescription drug · ANDA
Vitamin D (ergocalciferol) NDC 51655-774
Ergocalciferol 1.25 mg/1 · Capsule · Oral · Northwind Health Company, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51655-774-27 | 51655077427 | 12 CAPSULE in 1 BOTTLE, PLASTIC (51655-774-27)Marketed from Sep 21, 2022 | |
| 51655-774-52 | 51655077452 | 30 CAPSULE in 1 BOTTLE, PLASTIC (51655-774-52)Marketed from Jan 27, 2023 | |
| 51655-774-80 | 51655077480 | 8 CAPSULE in 1 BOTTLE, PLASTIC (51655-774-80)Marketed from Aug 29, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Vitamin D
- Generic name (nonproprietary)
- ergocalciferol
- Active ingredients
- Ergocalciferol — 1.25 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 090455
- Marketing start
- Listing expires
- Other FDA classes
- Ergocalciferols (Chemical structure)
- Identifiers
- Product ID 51655-774_49739ebf-fa64-df44-e063-6294a90a2ea2SPL ID 49739ebf-fa64-df44-e063-6294a90a2ea2SPL set ID f3402462-5d86-b4c9-e053-2a95a90aaab0RxCUI 1367410UNII VS041H42XC
- Pharmacologic class
- Provitamin D2 Compound
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451655077427followed by a unit qualifier and the quantityPackage 51655-0774-27. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Ergocalciferol Capsules, USP are indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin D resistant rickets, and familial hypophosphatemia.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 090455
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Vitamin Dergocalciferol | Ergocalciferol 1.25 mg/1 | CapsuleOral | REMEDYREPACK INC. | 70518-1878 |
| Vitamin Dergocalciferol | Ergocalciferol 1.25 mg/1 | CapsuleOral | Bryant Ranch Prepack | 71335-0278 |
| Vitamin Dergocalciferol | Ergocalciferol 1.25 mg/1 | CapsuleOral | PD-Rx Pharmaceuticals, Inc. | 72789-249 |
| Vitamin Dergocalciferol | Ergocalciferol 1.25 mg/1 | CapsuleOral | AvPAK | 50268-297 |
| Vitamin Dergocalciferol | Ergocalciferol 1.25 mg/1 | CapsuleOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-552 |
| Vitamin Dergocalciferol | Ergocalciferol 1.25 mg/1 | CapsuleOral | Golden State Medical Supply, Inc. | 51407-700 |
| Vitamin Dergocalciferol | Ergocalciferol 1.25 mg/1 | CapsuleOral | Strides Pharma Science Limited | 64380-737 |
| Vitamin Dergocalciferol | Ergocalciferol 1.25 mg/1 | CapsuleOral | Preferred Pharmaceuticals, Inc. | 68788-7627 |
| Vitamin Dergocalciferol | Ergocalciferol 1.25 mg/1 | CapsuleOral | Proficient Rx LP | 63187-519 |